Tone Bjørge

Title: Professor

Phone: +47 55 58 85 30

E-mail: Tone.Bjorge@isf.uib.no

Visiting address: Kalfarveien 31

Cancer epidemiology

MD, consultant pathologist

PhD in cancer epidemiology

Publications in Cristin

20 selected publications (in chronological order):

1. Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315: 646-9.

2. Bjørge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57: 3989-92.

3. Engeland A, Bjørge T, Selmer RM, Tverdal A. Height and body-mass index in relation to total mortality. Epidemiology 2003; 14: 293-9.

4. Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer - a follow-up of 1,1 million Norwegian women. J Natl Cancer Inst 2003; 95: 1244-8.

5. Engeland A, Bjørge T, Tverdal Aa, Søgaard AJ. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79-85.

6. Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. Br J Cancer 2004; 91: 1829-34.

7. Bjørge T, Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 2004; 160: 1168-76.

8. Bjørge T, Engeland A, Tretli, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 2007; 120: 378-83.

9. Engeland A , Tretli S, Hansen S, Bjørge T. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 2007; 165: 44-52.

10. Bjørge T, Cnattingius S, Lie RT, Tretli S, Engeland A. Cancer risk in families of children with birth defects. A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 2008; 17: 500-6.

11. Bjørge T, Engeland A, Tverdal A, Davey Smith G. Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. Am J Epidemiol 2008; 168: 30-7.

12. Bjørge T, Engeland A, Tretli S, Heuch I. Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. Br J Cancer 2008; 99: 1165-9. (DOI: 10.1038/sj.bjc.6604646)

13. Bjørge T, Cnattingius S, Engeland A, Tretli S, Lie RT, Lukanova A. Fetal Down syndrome and the risk of maternal breast cancer. Epidemiology 2009; 20; 584-9. (DOI: 10.1097/EDE.0b013e3181a66457)

14. Stocks T, Rapp K, Bjørge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Concin H, Tretli S, Hallmans G, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the Metabolic syndrome and Cancer project (Me-Can). PLoS Med 6(12): e1000201. doi:10.1371/journal.pmed.1000201.

15. Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010; 171: 892-902.

16. Tandberg A, Bjørge T, Nygård O, Børdahl PE, Skjærven R. Trends in incidence and mortality for triplets in Norway 1967-2006: The influence of assisted reproductive technologies. BJOG 2010; 117: 667-75.

17. Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A. Metabolic syndrome and breast cancer in the Me-Can (Metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19: 1737-45.

18. Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierød M, Jonsson H, Stattin P. Metabolic factors and risk of colorectal cancer  in 580,000 men and women in the Metabolic syndrome and Cancer project (Me-Can): A pooled cohort study. Cancer 2010, Epub.

19. Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf 2011; 20: 243-8.

20. Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol 2011; 26: 157-63.

• Teaching at courses in epidemiology for medical and PhD students
• Supervision of medical, PhD and postdoctoral students doing project work in epidemiology

• Cancer risk in families of children with birth defects: Cohort study of cancer risk among all individuals with birth defects in Norway and Sweden and their parents and siblings
• Birth characteristics in relation to cancer among children and adolescents: Population-based Norwegian cohort study, with data from the medical birth and cancer registries of Norway
• Metabolic syndrome and cancer (Me-Can): Population-based cohort study (with participating cohorts from Norway, Sweden and Austria) of the relation between factors in the metabolic syndrome and cancer risk
• Folate metabolism and cancer: Evaluation of the relation between serum folate, other B-vitamins, metabolites, biomarkers and polymorphisms in genes (SNPs) involved in the folate metabolism and cancer risk. The study is based on data from the Hordaland Homocysteine and Health Studies and the Janus Serum Bank
• Supplemental folic acid in pregnancy and later health consequences for the mother and the child
• Long-term consequences of cancer in childhood and adolescence: Registry-based national cohort study of later medical and social disabilities in individuals diagnosed with cancer in childhood and adolescence (below 25 years of age)